{"title":"Determination of Antithyroid drug Propylthiouracil with Ru (III) in Pharmaceutical formulations and its characterization","authors":"Afraim Koty, Mukul Sharma","doi":"10.2174/1573412919666230524140341","DOIUrl":"https://doi.org/10.2174/1573412919666230524140341","url":null,"abstract":"\u0000\u0000Sulfur serves as a versatile element and an essential constituent of pharmaceutical industries, natural compounds, proteins, and biological systems. One of the fundamental constituents of sulfur is thiouracil, which forms several derivatives, including 6-methylthiouracil, 6-methyl-2-thiouracil, and 6-propylthiouracil. These derivatives act as effective chelating agents and can form complexes with metal ions.\u0000\u0000\u0000\u0000Sulfur serves as a versatile element and an essential constituent of pharmaceutical industries, natural compounds, proteins, and biological systems. One of the fundamental constituents of sulfur is thiouracil, which forms several derivatives, including 6-methylthiouracil, 6-methyl-2-thiouracil, and 6-propylthiouracil. These derivatives act as effective chelating agents and can form complexes with metal ions.\u0000Compared with other metals, ruthenium possesses unique chemical properties that make it an ideal therapeutic agent. Therefore, this study reports on the propylthiouracil: Ru(III) complex, considering these essential facts.\u0000\u0000\u0000\u0000An equimolar amount of ruthenium trichloride 3.34 x 10-5 M was added to various aliquots ranging from 0.4 mL to 8.8 mL of 3.26 x 10−5 M propylthiouracil. The volume was adjusted to 10 mL with double distilled water. After letting the solution stand for 10 min, we recorded the absorbance of different sets at λmax 376 nm. The Beer-Lambert's law graph demonstrated linearity in the concentration range of 3.18 x101 gmL-1 to 7.96 x102 gmL-1, with a linear regression equation of Y = 0.0354 + 0.1109 X. We determined the effective molar absorptivity (ε) to be 6.609 x 102 Lmole-1 cm-1, and the relative standard deviation (RSD %) was ± 0.34%.\u0000\u0000\u0000\u0000At room temperature, a yellow-colored complex of propylthiouracil: Ru(III) was formed within 10 min, with a λmax of 376 nm and constant color intensity for 24 h. We confirmed and characterized the formed complex using FTIR, ESR, 1HNMR, thermal analysis, magnetic susceptibility, and powder X-ray.\u0000\u0000\u0000\u0000This approach is notable for its precision, accuracy, rapidity, cost-effectiveness, and applicability in tablet form. The novel propylthiouracil: Ru(III) complex offers several advantages, including stability, low absorbance, and no interference with water-soluble ions, eliminating the need for an organic solvent to extract the reaction product. Therefore, this approach could be recommended for quality control in the pharmaceutical industry.\u0000","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49559722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Chopra, Prashant K. Chaturvedi, Kalyani H. Joshi, S. Tauro, Pintu B. Prajapati
{"title":"Pitfalls and Opportunities in the Execution of Quality by Design in Analytical\u0000Sciences","authors":"S. Chopra, Prashant K. Chaturvedi, Kalyani H. Joshi, S. Tauro, Pintu B. Prajapati","doi":"10.2174/1573412919666230517141015","DOIUrl":"https://doi.org/10.2174/1573412919666230517141015","url":null,"abstract":"\u0000\u0000Quality by Design (QbD) is a systematic approach integrated with quality risk management.\u0000It uses different design approaches followed by statistical analysis to yield a quality\u0000product. Now, the pharmaceutical industries are intrested in the application of QbD principles to\u0000analytical methods and term it as Analytical QbD (AQbD), which does not essentially mean less\u0000analytical testing; to a particular extent, it means the right analysis at the right time, supported by\u0000science and risk evaluation which ensures that the analytical method can be improved throughout\u0000its life cycle. However, for that, the analyst must have sound knowledge of Analytical Target Profile\u0000(ATP), method performance characteristics, risk assessment, choice of Design of Experiment\u0000(DoE), optimization of Method Operable Design Region (MODR). Some papers have cited the\u0000importance, regulatory flexibility, theoretical aspects, and statistical analysis of AQbD, but only a\u0000few discuss the core issue of gradual implementation of QbD in analytical sciences. For seamless\u0000transition, researchers need clarification on AQbD terminologies, acceptable methods, criteria to\u0000embrace critical quality attributes (CQAs), and standards to judge the adequacy of controls. This\u0000paper summarizes the challenges and solutions for the implementation of AQbD.\u0000","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44426209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}